论文部分内容阅读
目的观察小剂量尿激酶治疗慢性肺原性心脏病的疗效。方法选取120例慢性肺原性心脏病患者,随机分为尿激酶加常规治疗组60例(常规组),常规治疗组60例(对照组)。观察心功能改善情况、平均住院日、治疗前后血气变化及血流变改善情况。结果治疗组平均住院日低于对照组(P<0.05)。结论小剂量尿激酶治疗慢性肺原性心脏病的疗效好。
Objective To observe the efficacy of low-dose urokinase in the treatment of chronic pulmonary heart disease. Methods A total of 120 patients with chronic pulmonary heart disease were enrolled and randomly divided into 60 patients (conventional group) and 60 patients in the conventional treatment group (control group). To observe the improvement of cardiac function, the average length of stay, blood gas changes before and after treatment and improvement of blood flow. Results The average length of stay in treatment group was lower than that in control group (P <0.05). Conclusion Low-dose urokinase is effective in treating chronic pulmonary heart disease.